Search

Zimmer Biomet Holdings Inc

Gesloten

SectorGezondheidszorg

95 0.81

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

95

Max

95.82

Belangrijke statistieken

By Trading Economics

Inkomsten

-39M

200M

Verkoop

90M

2.2B

K/W

Sectorgemiddelde

23.432

56.432

EPS

2.07

Dividendrendement

1.03

Winstmarge

9.169

Werknemers

17,000

EBITDA

-210M

328M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+11.23% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

1.03%

2.27%

Volgende Winsten

4 nov 2026

Volgende dividenddatum

30 okt 2026

Volgende Ex Dividend datum

29 sep 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-348M

18B

Vorige openingsprijs

94.19

Vorige sluitingsprijs

95

Nieuwssentiment

By Acuity

25%

75%

28 / 339 Rangschikking in Healthcare

Zimmer Biomet Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 sep 2026, 21:51 UTC

Zimmer Biomet Holdings, Inc. is advancing in after-market trading, moving higher alongside the broader market despite concerns over U.S. economic momentum.

16 sep 2026, 20:07 UTC

Zimmer Biomet Holdings, Inc. shares fell sharply, retracing from earlier gains and remaining below the 20-day moving average amid a decline since Tuesday's close.

15 sep 2026, 20:03 UTC

Zimmer Biomet shares are higher today, continuing positive momentum from Monday. This follows an early dip amid broader market concerns over New York's manufacturing sector.

14 sep 2026, 22:01 UTC

Zimmer Biomet Holdings shares are higher in after-market trading, continuing a trend of gains since Monday's close. No specific news was identified.

11 sep 2026, 23:46 UTC

Zimmer Biomet Holdings shares advanced in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

10 sep 2026, 20:03 UTC

Zimmer Biomet Holdings is declining during Thursday's session, continuing a downward trend since Wednesday's close with no specific news identified for the movement.

9 sep 2026, 22:51 UTC

Zimmer Biomet Holdings is trading lower in after-market hours amid a broader decline in U.S. stocks linked to rising crude oil prices above $100.

8 sep 2026, 21:02 UTC

News

Zimmer Biomet announced leadership promotions to enhance its strategy and reaffirmed its 2026 financial outlook. Shares are higher in after-market trading.

4 sep 2026, 20:07 UTC

Shares of Zimmer Biomet Holdings are lower today, amid increased selling pressure following a strong jobs report. The stock remains below its 20-day moving average.

2 sep 2026, 20:08 UTC

Zimmer Biomet shares are higher today, benefiting from significant advances in Health Care Equipment stocks. No specific news was identified to explain the movement.

1 sep 2026, 21:51 UTC

Zimmer Biomet Holdings shares are higher in after-market trading, nearing the top of their one-month range, amid broader market volatility and rising crude oil prices.

31 aug 2026, 20:07 UTC

Shares of Zimmer Biomet Holdings are trading lower amid market pressure from heightened interest rate hike expectations following the Jackson Hole Economic Symposium.

28 aug 2026, 19:16 UTC

Zimmer Biomet Holdings is trading higher during Friday's session, maintaining a position above its 20-day moving average and near the upper end of its one-month range.

27 aug 2026, 20:02 UTC

Zimmer Biomet Holdings, Inc. shares are lower as Health Care Equipment stocks face pressure, marking a shift from recent upward trends. No specific news was identified.

26 aug 2026, 19:26 UTC

Zimmer Biomet Holdings is trading higher, supported by strength above its 20-day moving average amid broader market dynamics and rising U.S. consumer prices.

25 aug 2026, 23:31 UTC

Zimmer Biomet Holdings is trading lower in after-market hours. This decline comes amid broader market sentiment impacted by a significant drop in crude oil prices.

24 aug 2026, 19:46 UTC

Zimmer Biomet Holdings is trading higher today, with shares near the upper end of their one-month range amid rising oil prices and geopolitical tensions.

22 aug 2026, 00:01 UTC

Zimmer Biomet Holdings Inc. shares are lower in after-market hours, reflecting broader weakness despite remaining above the 20-day moving average.

21 aug 2026, 23:01 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours, with no specific news identified. Recent bond market volatility may be influencing trader sentiment.

19 aug 2026, 20:06 UTC

Zimmer Biomet Holdings Inc is trading higher today, marking a shift from its recent trend of higher daily closes since Tuesday. No specific news was identified.

18 aug 2026, 19:16 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. reported first-quarter revenue of $2.05 billion, exceeding estimates. Shares are advancing amid raised full-year guidance and positive sector sentiment.

17 aug 2026, 20:02 UTC

Zimmer Biomet Holdings Inc shares are lower today, continuing a decline since Friday amid broader market pressures and rising crude oil prices.

14 aug 2026, 19:26 UTC

News

Zimmer Biomet Holdings Inc. shares are higher following Q2 earnings that topped estimates, with revenue of $2.18 billion and adjusted EPS of $2.07.

13 aug 2026, 19:46 UTC

Shares of Zimmer Biomet Holdings are trading higher, remaining strong near the upper end of their one-month range amid positive broader market sentiment.

12 aug 2026, 23:21 UTC

Zimmer Biomet Holdings Inc. shares are roughly flat in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

11 aug 2026, 23:02 UTC

Zimmer Biomet Holdings Inc. shares are higher in after-market trading, moving within a range above its 20-day moving average and near a one-month high.

10 aug 2026, 19:56 UTC

Correlated Moves
News

Canaccord raised Zimmer Biomet's price target to $100 from $83, maintaining a Hold rating. Shares are higher since Friday's close amid market strength.

7 aug 2026, 19:46 UTC

News

Zimmer Biomet shares are lower today as Truist maintains a Hold rating but raises the price target to $106 amid cautious market conditions.

6 aug 2026, 19:52 UTC

News

Zimmer Biomet shares are lower today, despite price target increases from RBC, BMO, and Wells Fargo. This marks a shift from recent higher daily closes.

5 aug 2026, 23:02 UTC

News

Stifel raised the price target on Zimmer Biomet to $110 from $105, maintaining a Buy rating. Shares are higher in after-market trading.

Peer Vergelijking

Prijswijziging

Zimmer Biomet Holdings Inc Prognose

Koersdoel

By TipRanks

11.23% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 106.067 USD  11.23%

Hoogste 120 USD

Laagste 93 USD

Gebaseerd op 18 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zimmer Biomet Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

18 ratings

6

Buy

12

Hold

0

Sell

Sentiment

By Acuity

28 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.